Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment

References

• United Nations Office on Drugs and Crime (UNODC). World Drug Report 2016; [cited 2017 May 11]; Available from: www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf.
   Google Scholar
• Azofeifa A, Mattson ME, Schauer G, et al. National estimates of marijuana use and related indicators – National Survey on Drug Use and Health, United States, 2002–2014. MMWR Surveill Summ. 2016;65:1–25.
   PubMed Web of Science ®Google Scholar
• Wilkinson ST, Yarnell S, Radhakrishnan R, et al. Marijuana legalization: impact on physicians and public health. Annu Rev Med. 2016;67:453–466.
   PubMed Web of Science ®Google Scholar
• ElSohly MA, Mehmedic Z, Foster S, et al. Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States. Biol Psychiatry. 2016;79:613–619.
   PubMed Web of Science ®Google Scholar
• Kim HS, Anderson JD, Saghafi O, et al. Cyclic vomiting presentations following marijuana liberalization in Colorado. Acad Emerg Med. 2015;22:694–699.
   PubMed Web of Science ®Google Scholar
• Bruguera P, López-Pelayo H, Miquel L, et al. Elevada prevalencia del síndrome de hiperémesis cannábica en pacientes consumidores de cánnabis. Emergencias 2016;28:249–251.
   Google Scholar
• Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis use. Gut 2004;53:1566–1570.
   PubMed Web of Science ®Google Scholar
• Kim HS, Monte AA. Colorado cannabis legalization and its effect on emergency care. Ann Emerg Med. 2016;68:71–75.
   PubMed Web of Science ®Google Scholar
• Maxwell JC, Mendelson B. What do we know now about the impact of the laws related to marijuana? J Addict Med. 2016;10:3–12.
   PubMed Web of Science ®Google Scholar
• Darmani NA. Cannabinoid-induced hyperemesis: a conundrum-from clinical recognition to basic science mechanisms. Pharmaceuticals (Basel). 2010;3:2163–2177.
   PubMedGoogle Scholar
• Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev. 2011;4:241–249.
   PubMedGoogle Scholar
• Simonetto DA, Oxentenko AS, Herman ML, et al. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012;87:114–119.
   PubMed Web of Science ®Google Scholar
• Richards JR, Gordon BK, Danielson AR, et al. Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review. Pharmacotherapy 2017;37:725–734.
   PubMed Web of Science ®Google Scholar
• Lapoint J. Capsaicin cream for treatment of cannabinoid hyperemesis syndrome. J Med Toxicol. 2014;10:77.
   Google Scholar
• Lapoint J. Case series of patients treated for cannabinoid hyperemesis syndrome with capsaicin cream. Clin Toxicol. 2014;52:707. (Abstract)
   Web of Science ®Google Scholar
• Biary R, Oh A, Lapoint J, et al. Topical capsaicin cream used as a therapy for cannabinoid hyperemesis syndrome. Clin Toxicol. 2014;52:787. (Abstract)
   Web of Science ®Google Scholar
• Román F, Llorens P, Burillo-Putze G. Topical capsaicin cream in the treatment for cannabinoid hyperemesis syndrome. Med Clin (Barc). 2016;147:517–518.
   PubMed Web of Science ®Google Scholar
• Burillo-Putze G, Llorens P. Perspectives in the treatment for cannabinoid hyperemesis syndrome. Adicciones 2017;29:134–135.
   PubMed Web of Science ®Google Scholar
• Dezieck L, Hafez Z, Conicella A, et al. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: A case series. Clin Toxicol. Forthcoming. [cited 11 May 2017]. DOI:10.1080/15563650.2017.1324166.
   Web of Science ®Google Scholar
• Hayman M, Kam PCA. Capsaicin: a review of its pharmacology and clinical applications. Curr Anaesth Crit Care. 2008;19:338–343.
   Google Scholar
• Senese F, Fire and spice: the molecular basis of flavor; [cited 2017 May 11]; Available at: antoine.frostburg.edu/chem/senese/101/features/capsaicin.shtml.
   Google Scholar
• Sawynok J. Topical analgesics in neuropathic pain. Curr Pharm Des. 2005;11:2995–3004.
   PubMed Web of Science ®Google Scholar
• Perry L, Dickau R, Zarrillo S, et al. Starch fossils and the domestication and dispersal of chili peppers (Capsicum spp. L.) in the Americas. Science. 2007;315:986–968.
   PubMed Web of Science ®Google Scholar
• Scoville WC. Note on capsicums. J Am Pharm Assoc. 1912;1:453–454.
   Google Scholar
• Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 1999;51:159–212.
   PubMed Web of Science ®Google Scholar
• Bode AM, Dong Z. The two faces of capsaicin. Cancer Res. 2011;71:2809–2814.
   PubMed Web of Science ®Google Scholar
• Babbar S, Marier JF, Mouksassi MS, et al. Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit. 2009;31:502–510.
   PubMed Web of Science ®Google Scholar
• Reilly CA, Yost GS. Structural and enzymatic parameters that determine alkyl dehydrogenation/hydroxylation of capsaicinoids by cytochrome p450 enzymes. Drug Metab Dispos. 2005;33:530–536.
   PubMed Web of Science ®Google Scholar
• Chanda S, Bashir M, Babbar S, et al. In vitro hepatic and skin metabolism of capsaicin. Drug Metab Dispos. 2008;36:670–675.
   PubMed Web of Science ®Google Scholar
• Turnbull A. Tincture of capsaicin as a remedy for chilblains and toothache. Dublin Free Press 1850;1:95–96.
   Google Scholar
• Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging.1995;7:317–328.
   PubMed Web of Science ®Google Scholar
• Baranidharan G, Das S, Bhaskar A. A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic pain. Ther Adv Neurol Disord. 2013;6:287–297.
   PubMed Web of Science ®Google Scholar
• Derry S, Rice AS, Cole P, et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;1:CD007393.
   PubMed Web of Science ®Google Scholar
• Jancsó N, Jancsó-Gábor A, Szolcsányi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother. 1967;31:138–151.
   PubMed Web of Science ®Google Scholar
• Szolcsányi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides. 2004;38:377–384.
   PubMed Web of Science ®Google Scholar
• Montell C, Rubin GM. Molecular characterization of the Drosophila TRP locus: a putative integral membrane protein required for phototransduction. Neuron. 1989;2:1313–1323.
   PubMed Web of Science ®Google Scholar
• Bevan S, Szolcsányi J. Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci. 1990;11:330–333.
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816–824.
   PubMed Web of Science ®Google Scholar
• Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991;43:143–201.
   PubMed Web of Science ®Google Scholar
• Kárai LJ, Russell JT, Iadarola MJ, et al. Vanilloid receptor 1 regulates multiple calcium compartments and contributes to Ca2+-induced Ca2+ release in sensory neurons. J Biol Chem. 2004;279:16377–16387.
   PubMed Web of Science ®Google Scholar
• Clapham DE, Runnels LW, Strubing C. The TRP ion channel family. Nat Rev Neurosci. 2001;2:387–396.
   PubMed Web of Science ®Google Scholar
• Starowicz K, Nigam S, Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol Ther. 2007;114:13–33.
   PubMed Web of Science ®Google Scholar
• Benarroch EE. Synaptic effects of cannabinoids: complexity, behavioral effects, and potential clinical implications. Neurology. 2014;83:1958–1967.
   PubMed Web of Science ®Google Scholar
• Pertwee RG. Endocannabinoids and their pharmacological actions. Handb Exp Pharmacol. 2015;231:1–37.
   PubMedGoogle Scholar
• Chen J, Varga A, Selvarajah S, et al. Spatial distribution of the cannabinoid type 1 and capsaicin receptors may contribute to the complexity of their crosstalk. Sci Rep. 2016;6:33307.
   PubMed Web of Science ®Google Scholar
• Van Der Stelt M, Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem. 2004;271:1827–1834.
   PubMedGoogle Scholar
• Akerman S, Kaube H, Goadsby PJ. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther. 2004;309:56–63.
   PubMed Web of Science ®Google Scholar
• Akerman S, Kaube H, Goadsby PJ. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol. 2004;142:1354–1360.
   PubMed Web of Science ®Google Scholar
• Engel MA, Izydorczyk I, Mueller-Tribbensee SM, et al. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin. Neuropeptides. 2011;45:229–237.
   PubMed Web of Science ®Google Scholar
• Marichal-Cancino BA, Altamirano-Espinoza AH, Manrique-Maldonado G, et al. Role of pre-junctional CB1, but not CB2, TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats. Basic Clin Pharmacol Toxicol. 2014;114:240–247.
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Supronsinchai W, Andreou AP, et al. Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system. Pain. 2012;153:2226–2232.
   PubMed Web of Science ®Google Scholar
• Levinthal DJ, Bielefeldt K. Adult cyclical vomiting syndrome: a disorder of allostatic regulation? Exp Brain Res. 2014;232:2541–2547.
   PubMed Web of Science ®Google Scholar
• Richards JR. Cannabinoid hyperemesis syndrome: a disorder of the HPA axis and sympathetic nervous system? Med Hypotheses. 2017;103:90–95.
   PubMed Web of Science ®Google Scholar
• Moreira FA, Aguiar DC, Terzian AL, et al. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? Neuroscience. 2012;204:186–192.
   PubMed Web of Science ®Google Scholar
• Di Marzo V, De Petrocellis L. Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs. Curr Med Chem. 2010;17:1430–1449.
   PubMed Web of Science ®Google Scholar
• Sanger GJ, Chang L, Bountra C, et al. Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. Therap Adv Gastroenterol. 2010;3:291–305.
   PubMedGoogle Scholar
• Larauche M, Mulak A, Tache Y. Stress and visceral pain: from animal models to clinical therapies. Exp Neurol. 2012;233:49–67.
   PubMed Web of Science ®Google Scholar
• Hong S, Fan J, Kemmerer ES, et al. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat. Gut. 2009;58:202–210.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Verne GN. miRNA-based therapies for the irritable bowel syndrome. Expert Opin Biol Ther. 2011;11:991–995.
   PubMed Web of Science ®Google Scholar
• Hong S, Zheng G, Wiley JW. Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system. Gastroenterology. 2015;148:148–157.e7.
   PubMed Web of Science ®Google Scholar
• Lee SH, Ledri M, Tóth B, et al. Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release. J Neurosci. 2015;35:10039–10057.
   PubMed Web of Science ®Google Scholar
• Gaston TE, Friedman D. Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy Behav. 2017;70:313–318.
   PubMed Web of Science ®Google Scholar
• Izzo AA, Borrelli F, Capasso R, et al. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009;30:515–527.
   PubMed Web of Science ®Google Scholar
• Morales P, Hurst DP, Reggio PH. Molecular targets of the phytocannabinoids: a complex picture. Prog Chem Org Nat Prod. 2017;103:103–131.
   PubMedGoogle Scholar
• Iannotti FA, Hill CL, Leo A, et al. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci. 2014;5:1131–1141.
   PubMed Web of Science ®Google Scholar
• Chang YH, Windish D. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84:76–78.
   PubMed Web of Science ®Google Scholar
• Wenger T, Moldrich G. The role of endocannabinoids in the hypothalamic regulation of visceral function. Prostaglandins Leukot Essent Fatty Acids. 2002;66:301–307.
   PubMed Web of Science ®Google Scholar
• Thomas KN, van Rij AM, Lucas SJ, et al. Lower-limb hot-water immersion acutely induces beneficial hemodynamic and cardiovascular responses in peripheral arterial disease and healthy, elderly controls. Am J Physiol Regul Integr Comp Physiol. 2016;312:R281–R291.
   PubMed Web of Science ®Google Scholar
• Nagasawa Y, Komori S, Sato M, et al. Effects of hot bath immersion on autonomic activity and hemodynamics: comparison of the elderly patient and the healthy young. Jpn Circ J. 2001;65:587–592.
   PubMedGoogle Scholar
• Figueroa-Rivera IM, Estremera-Marcial R, Sierra-Mercado M, et al. Cannabinoid hyperemesis syndrome: a paradoxical cannabis effect. Case Rep Gastrointest Med. 2015;2015:405238.
   PubMedGoogle Scholar
• Gavva NR. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci. 2008;29:550–557.
   PubMed Web of Science ®Google Scholar
• Fosgerau K, Weber UJ, Gotfredsen JW, et al. Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist. BMC Cardiovasc Disord. 2010;10:51.
   PubMed Web of Science ®Google Scholar
• Cao Z, Balasubramanian A, Marrelli SP. Pharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion. Am J Physiol Regul Integr Comp Physiol. 2014;306:R149–R156.
   PubMed Web of Science ®Google Scholar
• Gavva NR, Treanor JJ, Garami A, et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain. 2008;136:202–210.
   PubMed Web of Science ®Google Scholar
• Carnevale V, Rohacs T. TRPV1: a target for rational drug design. Pharmaceuticals (Basel). 2016;9:pii:E52.
   PubMedGoogle Scholar
• Han P, McDonald HA, Bianchi BR, et al. Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes. Biochem Pharmacol. 2007;73:1635–1645.
   PubMed Web of Science ®Google Scholar
• Shimomura Y, Kawada T, Suzuki M. Capsaicin and its analogs inhibit the activity of NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain. Arch Biochem Biophys. 1989;270:573–577.
   PubMed Web of Science ®Google Scholar
• Lukacs V, Yudin Y, Hammond GR, et al. Distinctive changes in plasma membrane phosphoinositides underlie differential regulation of TRPV1 in nociceptive neurons. J Neurosci. 2013;33:11451–11463.
   PubMed Web of Science ®Google Scholar
• Rohacs T. Phosphoinositide regulation of TRPV1 revisited. Pflugers Arch. 2015;467:1851–1869.
   PubMed Web of Science ®Google Scholar
• Sanz-Salvador L, Andrés-Borderia A, Ferrer-Montiel A, et al. Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation. J Biol Chem. 2012;287:19462–19471.
   PubMed Web of Science ®Google Scholar
• Docherty RJ, Yeats JC, Bevan S, et al. Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Arch. 1996;431:828–837.
   PubMed Web of Science ®Google Scholar
• Numazaki M, Tominaga T, Takeuchi K, et al. Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc Natl Acad Sci USA. 2003;100:8002–8006.
   PubMed Web of Science ®Google Scholar
• Nolano M, Simone DA, Wendelschafer-Crabb G, et al. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 1999;81:135–145.
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288:306–313.
   PubMed Web of Science ®Google Scholar
• Amaya F, Shimosato G, Nagano M, et al. NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur J Neurosci. 2004;20:2303–2310.
   PubMed Web of Science ®Google Scholar
• Yu L, Yang F, Luo H, et al. The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant. Mol Pain. 2008;4:61.
   PubMed Web of Science ®Google Scholar
• Varga A, Bölcskei K, Szöke E, et al. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo. Neuroscience. 2006;140:645–657.
   PubMed Web of Science ®Google Scholar
• Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA. 2001;98:6951–6956.
   PubMed Web of Science ®Google Scholar
• Wasilewski A, Lewandowska U, Mosinska P, et al. Cannabinoid receptor type 1 and mu-opioid receptor polymorphisms are associated with cyclic vomiting syndrome. Am J Gastroenterol. 2017;112:933–939.
   PubMed Web of Science ®Google Scholar
• van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain. 2010;11:408–419.
   PubMed Web of Science ®Google Scholar
• Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain. 1997;13:189–196.
   PubMed Web of Science ®Google Scholar
• Wilder-Smith CH, Schindler D, Lovblad K, et al. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut. 2004;53:1595–1601.
   PubMed Web of Science ®Google Scholar
• Price DD, McHaffie JG. Effects of heterotopic conditioning stimuli on first and second pain: a psychophysical evaluation in humans. Pain. 1988;34:245–252.
   PubMed Web of Science ®Google Scholar
• Witting N, Svensson P, Arendt-Nielsen L, et al. Differential effect of painful heterotopic stimulation on capsaicin-induced pain and allodynia. Brain Res. 1998;801:206–210.
   PubMed Web of Science ®Google Scholar
• Valeriani M, Tinazzi M, Le Pera D, et al. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials. Exp Brain Res. 2005;160:29–37.
   PubMed Web of Science ®Google Scholar
• Hohmann AG, Suplita RL, Bolton NM, et al. An endocannabinoid mechanism for stress-induced analgesia. Nature. 2005;435:1108–1112.
   PubMed Web of Science ®Google Scholar
• Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111 Suppl 8A:106S–112S.
   PubMed Web of Science ®Google Scholar
• Zhong W, Picca AJ, Lee AS, et al. Ca(2+) signaling and emesis: recent progress and new perspectives. Auton Neurosci. 2017;202:18–27.
   PubMed Web of Science ®Google Scholar
• Hajna Z, Sághy É, Payrits M, et al. Capsaicin-sensitive sensory nerves mediate the cellular and microvascular effects of H2S via TRPA1 receptor activation and neuropeptide release. J Mol Neurosci. 2016;60:157–170.
   PubMed Web of Science ®Google Scholar
• Loyd DR, Chen PB, Hargreaves KM. Anti-hyperalgesic effects of anti-serotonergic compounds on serotonin- and capsaicin-evoked thermal hyperalgesia in the rat. Neuroscience. 2012;203:207–215.
   PubMed Web of Science ®Google Scholar
• Rudd JA, Nalivaiko E, Matsuki N, et al. The involvement of TRPV1 in emesis and anti-emesis. Temperature (Austin). 2015;2:258–276.
   PubMedGoogle Scholar
• Shiroshita Y, Koga T, Fukuda H. Capsaicin in the 4th ventricle abolishes retching and transmission of emetic vagal afferents to solitary nucleus neurons. Eur J Pharmacol. 1997;339:183–192.
   PubMed Web of Science ®Google Scholar
• Kim KS, Koo MS, Jeon JW, et al. Capsicum plaster at the Korean hand acupuncture point reduces postoperative nausea and vomiting after abdominal hysterectomy. Anesth Analg. 2002;95:1103–1107.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Dhiraaj S, Tandon M, et al. Evaluation of capsaicin ointment at the Korean hand acupressure point K-D2 for prevention of postoperative nausea and vomiting. Anaesthesia. 2005;60:1185–1188.
   PubMed Web of Science ®Google Scholar
• Misra MN, Pullani AJ, Mohamed ZU. Prevention of PONV by acustimulation with capsicum plaster is comparable to ondansetron after middle ear surgery. Can J Anaesth. 2005;52:485–489.
   PubMed Web of Science ®Google Scholar
• Koo MS, Kim KS, Lee HJ, et al. Antiemetic efficacy of capsicum plaster on acupuncture points in patients undergoing thyroid operation. Korean J Anesthesiol. 2013;65:539–543.
   PubMedGoogle Scholar
• Pintér E, Helyes Z, Szolcsányi J. Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther. 2006;112:440–456.
   PubMed Web of Science ®Google Scholar
• Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20:157–198.
   PubMed Web of Science ®Google Scholar
• Braun M. The somatostatin receptor in human pancreatic β-cells. Vitam Horm. 2014;95:165–193.
   PubMed Web of Science ®Google Scholar
• Malaisse WJ. Paracrine control of glucagon release by somatostatin (Review). Int J Mol Med. 2014;33:491–498.
   PubMed Web of Science ®Google Scholar
• Mózsik G, Szolcsányi J, Rácz I. Gastroprotection induced by capsaicin in healthy human subjects. World J Gastroenterol. 2005;11:5180–5184.
   PubMed Web of Science ®Google Scholar
• Yi CH, Lei WY, Hung JS, et al. Differences in the control of secondary peristalsis in the human esophagus: influence of the 5-HT4 receptor versus the TRPV1 receptor. PLoS One. 2016;11:e0159452.
   PubMed Web of Science ®Google Scholar
• Németh J, Reglödi D, Pozsgai G, et al. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience. 2006;143:223–230.
   PubMed Web of Science ®Google Scholar
• Holgert H, Holmberg K, Hannibal J, et al. PACAP in the adrenal gland–relationship with choline acetyltransferase, enkephalin and chromaffin cells and effects of immunological sympathectomy. Neuroreport. 1996;20:297–301.
   Web of Science ®Google Scholar
• Stroth N, Holighaus Y, Ait-Ali D, et al. PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Ann N Y Acad Sci. 2011;1220:49–59.
   PubMed Web of Science ®Google Scholar
• Hamelink C, Tjurmina O, Damadzic R, et al. Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci USA. 2002;99:461–466.
   PubMed Web of Science ®Google Scholar
• Ramikie TS, Ressler KJ. Stress-related disorders, pituitary adenylate cyclase-activating peptide (PACAP)ergic system, and sex differences. Dialogues Clin Neurosci. 2016;18:403–413.
   PubMed Web of Science ®Google Scholar
• Hammack SE, May V. Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies. Biol Psychiatry. 2015;78:167–177.
   PubMed Web of Science ®Google Scholar
• Stevens JS, Almli LM, Fani N, et al. PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus. Proc Natl Acad Sci USA. 2014;111:3158–3163.
   PubMed Web of Science ®Google Scholar
• Fischer MJ. Calcitonin gene-related peptide receptor antagonists for migraine. Expert Opin Investig Drugs. 2010;19:815–823.
   PubMed Web of Science ®Google Scholar
• Cianchetti C. Capsaicin jelly against migraine pain. Int J Clin Pract. 2010;64:457–459.
   PubMed Web of Science ®Google Scholar
• Fusco BM, Barzoi G, Agrò F. Repeated intranasal capsaicin applications to treat chronic migraine. Br J Anaesth. 2003;90:812.
   PubMed Web of Science ®Google Scholar
• Fusco BM, Marabini S, Maggi CA, et al. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain. 1994;59:321–325.
   PubMed Web of Science ®Google Scholar
• Marks DR, Rapoport A, Padla D, et al. A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgia. 1993;13:114–116.
   PubMed Web of Science ®Google Scholar
• Winner P. Abdominal migraine. Semin Pediatr Neurol. 2016;23:11–13.
   PubMed Web of Science ®Google Scholar
• Evans RW, Whyte C. Cyclic vomiting syndrome and abdominal migraine in adults and children. Headache. 2013;53:984–993.
   PubMed Web of Science ®Google Scholar
• Vass Z, Dai CF, Steyger PS, et al. Co-localization of the vanilloid capsaicin receptor and substance P in sensory nerve fibers innervating cochlear and vertebro-basilar arteries. Neuroscience. 2004;124:919–927.
   PubMed Web of Science ®Google Scholar
• Balaban CD, Zhou J, Li HS. Type 1 vanilloid receptor expression by mammalian inner ear ganglion cells. Hear Res. 2003;175:165–170.
   PubMed Web of Science ®Google Scholar
• Vass Z, Steyger PS, Hordichok AJ, et al. Capsaicin stimulation of the cochlea and electric stimulation of the trigeminal ganglion mediate vascular permeability in cochlear and vertebro-basilar arteries: a potential cause of inner ear dysfunction in headache. Neuroscience. 2001;103:189–201.
   PubMed Web of Science ®Google Scholar
• de Tommaso M, Sardaro M, Pecoraro C, et al. Effects of the remote C fibres stimulation induced by capsaicin on the blink reflex in chronic migraine. Cephalalgia. 2007;27:881–890.
   PubMed Web of Science ®Google Scholar
• Nicolson TA, Bevan S, Richards CD. Characterisation of the calcium responses to histamine in capsaicin-sensitive and capsaicin-insensitive sensory neurones. Neuroscience. 2002;110:329–338.
   PubMed Web of Science ®Google Scholar
• Taylor-Clark TE, Kollarik M, MacGlashan DW Jr, et al. Nasal sensory nerve populations responding to histamine and capsaicin. J Allergy Clin Immunol. 2005;116:1282–1288.
   PubMed Web of Science ®Google Scholar
• Brull SJ, Atanassoff PG, Silverman DG, et al. Attenuation of experimental pruritus and mechanically evoked dysesthesiae in an area of cutaneous allodynia. Somatosens Mot Res. 1999;16:299–303.
   PubMed Web of Science ®Google Scholar
• Shim WS, Tak MH, Lee MH, et al. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci. 2007;27:2331–2337.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Fast K, Bernhard JD. Noxious heat and scratching decrease histamine-induced itch and skin blood flow. J Invest Dermatol. 2005;125:1268–1272.
   PubMed Web of Science ®Google Scholar
• Schmelz M, Schmid R, Handwerker HO, et al. Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres. Brain. 2000;123:560–571.
   PubMed Web of Science ®Google Scholar
• Weisshaar E, Heyer G, Forster C, et al. Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin. Arch Dermatol Res. 1998;290:306–311.
   PubMed Web of Science ®Google Scholar
• Witting N, Svensson P, Arendt NL, et al. Repetitive intradermal capsaicin: differential effect on pain and areas of allodynia and punctate hyperalgesia. Somatosens Mot Res. 2000;17:5–12.
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Tashiro M, Kano M, et al. Imaging of central itch modulation in the human brain using positron emission tomography. Pain. 2003;105:339–346.
   PubMed Web of Science ®Google Scholar
• Andrews PL, Sanger GJ. Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr Opin Pharmacol. 2002;2:650–656.
   PubMed Web of Science ®Google Scholar
• Patterson LM, Zheng H, Ward SM, et al. Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res. 2003;311:277–287.
   PubMed Web of Science ®Google Scholar
• Sharkey KA, Oland LD, Kirk DR, et al. Capsaicin-sensitive vagal stimulation-induced gastric acid secretion in the rat: evidence for cholinergic vagal afferents. Br J Pharmacol. 1991;103:1997–2003.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Onaga T, Kitazawa T. Ghrelin stimulates gastric motility of the guinea pig through activation of a capsaicin-sensitive neural pathway: in vivo and in vitro functional studies. Neurogastroenterol Motil. 2010;22:446–452.
   PubMed Web of Science ®Google Scholar
• Lang PM, Grafe P. Chemosensitivity of unmyelinated axons in isolated human gastric vagus nerve. Auton Neurosci. 2007;136:100–104.
   PubMed Web of Science ®Google Scholar
• Blackshaw LA, Page AJ, Partosoedarso ER. Acute effects of capsaicin on gastrointestinal vagal afferents. Neuroscience. 2000;96:407–416.
   PubMed Web of Science ®Google Scholar
• Minami M, Endo T, Hirafuji M, et al. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol Ther. 2003;99:149–165.
   PubMed Web of Science ®Google Scholar
• Zhu JX, Zhu XY, Owyang C, et al. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol. 2001;530:431–442.
   PubMed Web of Science ®Google Scholar